Automation Workflow for Polypharmacy Risk Prediction and Management

Polypharmacy—the concurrent use of multiple medications—is a leading cause of adverse events and avoidable hospitalizations among the elderly. A custom automation workflow addresses this by continuously analyzing a patient's full medication list (prescription, OTC, supplements) against drug interaction databases, therapeutic duplication rules, and age-inappropriate prescribing guidelines. The operational bottleneck is the manual, error-prone review by clinicians. Automating this analysis flags critical risks in real-time, directly targeting a major source of clinical harm and cost.

Implementation integrates with EHRs like Epic or Cerner via HL7/FHIR, using a rules engine and LLM agents for nuanced guideline interpretation. The architecture requires strict controls: all high-risk flags must route through a clinician approval gate before any system-generated suggestions are communicated. The workflow includes continuous monitoring for data quality and model drift, with all decisions logged for auditability. The ROI comes from reduced adverse events, lower readmission penalties, and more efficient pharmacist and physician time.

This workflow automates the high-risk, manual process of reviewing complex medication lists for elderly patients. It ingests FHIR data from EHRs like Epic or Cerner, plus OTC and supplement lists, to flag interactions, therapeutic duplication, and Beers Criteria violations. The operational upside is a dramatic reduction in adverse drug events (ADEs), which drive billions in avoidable hospitalization costs annually, while freeing clinical pharmacists for high-value intervention instead of manual chart review.

Implementation requires a LangGraph or similar orchestration layer to manage agent execution, state, and exception handling. Each agent queries specialized knowledge bases (e.g., DrugBank, clinical guidelines) via RAG. The system integrates with clinician workflows via EHR in-basket alerts or a dedicated dashboard. Critical controls include configurable severity thresholds, mandatory human review for medium-confidence flags, and a full audit trail linking alerts to source data and review actions for compliance.

Phase 1 establishes the core data pipeline and rule-based engine, ingesting medication lists from EHRs like Epic or Cerner via FHIR APIs and checking for known severe interactions and therapeutic duplication. This initial automation layer delivers immediate value by flagging critical risks to pharmacists and physicians, reducing manual chart review for high-alert scenarios. The focus is on integrating with existing clinical workflows and building trust through transparent, explainable alerts before introducing predictive AI models.

Subsequent phases introduce LLM agents to analyze unstructured clinical notes for over-the-counter and supplement use, and predictive models to flag age-inappropriate prescriptions like long-acting benzodiazepines. Each capability is deployed behind a human-in-the-loop approval gate, where flagged recommendations are reviewed by a clinical pharmacist before reaching the prescriber. This controlled rollout, coupled with A/B testing of alert acceptance rates, de-risks the implementation, measures ROI in reduced adverse drug events, and ensures the system augments rather than disrupts clinical judgment.

This workflow directly targets a leading cause of hospitalizations in the elderly: adverse drug events from complex medication regimens. It automates the repetitive, high-risk task of manually reviewing a patient's full medication list—including prescriptions, OTC drugs, and supplements—against interaction databases and clinical guidelines. The operational upside comes from preventing costly readmissions, reducing pharmacist and physician review burden, and creating a systematic, auditable process for deprescribing conversations that improve patient safety and medication adherence.

Implementation integrates with Epic or Cerner via FHIR APIs, using a LangGraph orchestrator to manage agents for data extraction, interaction checking (e.g., Micromedex), and rule-based validation. Critical controls include configurable confidence thresholds for auto-flagging, mandatory human-in-the-loop review for high-severity risks, and a full audit trail logged back to the EHR. Rollout requires phased validation with pharmacy and clinical teams, starting with read-only alerts before enabling deprescribing suggestion workflows, ensuring safety and change management are prioritized.

This workflow automates the high-risk, manual process of polypharmacy review, directly targeting a leading cause of hospitalizations in the elderly. It ingests medication lists from EHRs like Epic or Cerner, plus OTC and supplement data from patient apps, to identify dangerous interactions, therapeutic duplication, and age-inappropriate prescriptions. The operational upside comes from preventing adverse events, reducing readmission penalties, and freeing clinician time from manual chart reviews for higher-value care coordination.

Implementation requires a robust data pipeline for HL7/FHIR ingestion and RxNorm normalization. The core logic, built with a rules engine and LLM for clinical guideline reasoning, generates risk scores and evidence-based alternative suggestions. Critical controls include mandatory physician review gates for high-severity flags, integration back into the EHR as a clinical decision support alert, and automated notifications to the dispensing pharmacy via platforms like Surescripts for coordinated intervention.